Nalaganje...
Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
Chagas disease, caused by the parasite Trypanosoma cruzi (T. cruzi), affects more than six million people worldwide, with its greatest burden in Latin America. Available treatments present frequent toxicity and variable efficacy at the chronic phase of the infection, when the disease is usually diag...
Shranjeno v:
| izdano v: | Microorganisms |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920067/ https://ncbi.nlm.nih.gov/pubmed/33669310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9020406 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|